Skip to main content

Table 4 Variables and effect estimates from the model

From: Evidence-based design recommendations for prevalence studies on multimorbidity: improving comparability of estimates

Characteristics

Categories

Effect estimate

95% CI

Mean age

Years

0.052

0.044, 0.061

Number of age groups

1

0

2

−2.7

−3.69, −1.71

3

0.391

−0.14, 0.92

4

0.474

−0.10, 1.05

5

0.102

−0.47, 0.67

6

0.001

−0.87, 0.87

Disease classification

Names of specific disease/disease groups

0

Diseases based on ICD-10 or ICD-9 codes

1.26

0.039, 2.49

Diseases based on ICPC-2 or CIRS

−0.789

−1.64, 0.067

No. of diseases in the classification

5–9

0

-

10–24

0.516

0.0017, 1.03

25–74

1.22

0.43, 2.01

≥75

0.806

−0.47, 2.08

Setting

General population

0

Primary care practice

0.015

−0.70, 0.73

Hospital/nursing home

1.41

0.39, 2.44

Health insurance

1.05

−0.66, 2.76

Data source

Self-report

0

Medical record

−0.863

−1.71, −0.019

Self-report + medical record

−0.75

−1.43, −0.071

Administrative data

−0.497

−2.39, 1.39

Data collection period

Up to one year

0

One year or more

−0.349

−0.79, 0.09

Data reporting quality

P2+ given in paper

0

P2+ calculated from paper

−0.4

−0.94, 0.14

P2+ read from graph in paper

−1.76

−2.52, −0.99

Constant

 

−3.305

−4.01, −2.60

  1. Legend: Random effects model with response: logit P2+, sampling weights inverse to binomial variance of logit P2+; average sampling weight: 0.0182. N = 108; adjusted R2 = 70.6%; residual variance τ2 = 0.5812; overall F(20,87) = 12.61; p < 0.00005
  2. Categories with “Effect estimate” = 0 are reference categories. Gender analyses were done using a different data set (see text). Mean age: Effect estimate gives the change in logit P2+ when changing mean age by one year. Other variables: Effect estimate quantifies the effect on logit P2+ of going from the reference category to the category of interest – e.g., going from one age group to two changes logit P2+ by −2.70, when keeping all other variables fixed (also see Discussion)